On November 23, 2021 IMV Inc. (Nasdaq: IMV; TSX: IMV) ("IMV" or "the Company"), a clinical-stage company developing a portfolio of immune-educating cancer therapies based on its novel DPX platform, reported that IMV’s executive management team will be participating in the upcoming Piper Sandler Virtual Healthcare Conference (Press release, IMV, NOV 23, 2021, View Source [SID1234595962]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On-demand starting Tuesday, November 23, 2021
11:00 a.m. ET
Format: Fireside chat
Actual conference: November 30 – December 2, 2021
A webcast of this presentation will be accessible in the ‘Events, Webcasts & Presentations’ section of IMV’s website. The webcast will then be archived, and a copy of the presentation will be available at www.imv-inc.com.